Keywords: pixantrone, fda, fast, track, nhl, cell, therapeutics

Pixantrone on FDA fast track for NHL

Article | 19 July 2004

Print This

Cell Therapeutics says it has received fast-track designation from theUS Food and Drug Administration for pixantrone, a potential new therapy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in